日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy.

EGFR突变型小细胞肺癌具有肿瘤内异质性,可通过MEK抑制剂联合疗法进行靶向治疗。

Ogino Atsuko, Vajdi Amir, Mu Xinmeng Jasmine, Mahadevan Navin R, Ngo Kenneth, Booker Matthew A, Cejas Paloma, Okoro Jeffrey J, Xu Man, Springer Benjamin F, Eschle Benjamin K, Messier Cameron M, Wang Stephen, Syamala Sudeepa, Tamen Rubii M, Adeni Anika E, Chambers Emily S, Canadas Israel, Thai Tran, Christensen Camilla L, Xu Chunxiao, Lizotte Patrick H, Oxnard Geoffrey R, Watanabe Hideo, Long Henry W, Gokhale Prafulla C, Paweletz Cloud P, Sholl Lynette M, Oser Matthew G, Barbie David A, Tolstorukov Michael Y, Jänne Pasi A

Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial

Selpercatinib治疗RET融合阳性非小细胞肺癌:LIBRETTO-001 I/II期试验的最终安全性和有效性,包括总生存期

Gautschi, Oliver; Park, Keunchil; Solomon, Benjamin J; Tomasini, Pascale; Loong, Herbert H; De Braud, Filippo; Goto, Koichi; Peterson, Patrick; Barker, Scott; Liming, Katherine; Oxnard, Geoffrey R; Frimodt-Moller, Bente; Drilon, Alexander

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types

在超过 8000 名涵盖 24 种癌症类型的患者中,肿瘤突变负荷与免疫检查点抑制剂治疗后的生存率之间的关系

Gandara, David R; Agarwal, Neeraj; Gupta, Shilpa; Klempner, Samuel J; Andrews, Miles C; Mahipal, Amit; Subbiah, Vivek; Eskander, Ramez N; Carbone, David P; Riess, Jonathan W; Sammons, Sarah; Snider, Jeremy; Bouzit, Lilia; Cho-Phan, Cheryl; Price, Megan; Li, Gerald; Quintanilha, Julia C F; Huang, Richard Sheng Poe; Ross, Jeffrey S; Fabrizio, David; Oxnard, Geoffrey R; Graf, Ryon P

Round-Robin Comparison of RET Rearrangement Detection in ctDNA: A Novel Method for Limited Clinical Samples

循环肿瘤DNA中RET重排检测的比较研究:一种适用于有限临床样本的新方法

Paweletz, Cloud P; Urvalek, Alison; Ha, Minh; Garg, Kavita; Bence Lin, Aimee; Szpurka, Anna M; Sireci, Anthony; Oxnard, Geoffrey R; Janne, Pasi A

ctDNA Clearance as an Early Indicator of Improved Clinical Outcomes in Advanced NSCLC Treated with TKI: Findings from an Aggregate Analysis of Eight Clinical Trials

ctDNA清除率作为TKI治疗晚期NSCLC患者临床疗效改善的早期指标:来自八项临床试验的汇总分析结果

Andrews, Hillary S; Zariffa, Nevine; Nishimura, Katherine K; Choi, Stephanie H; Deng, Shibing; Eisele, Megan; Espenschied, Carin R; Goren, Emily M; Guha, Minakshi; Hong, Samuel; Juraeva, Dilafruz; Krämer, Nicole; Liu, Li; Martini, Jean-Francois; McKelvey, Brittany A; Oxnard, Geoffrey R; Pestano, Gary A; Poole, Lynne; Rosenthal, Adam; Szpurka, Anna M; Vega, Diana Merino; Ward, Christine; Wijayawardana, Sameera R; Hoering, Antje; Stewart, Mark D; Allen, Jeff D

FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Optimized Dosages for Registrational Trials

FDA-AACR肿瘤药物产品剂量优化策略:注册试验的最佳剂量选择

Shord, Stacy S; Chen, Cong; Jin, Jin Y; Van Wart, Scott; Martin, Sarah K; Davidson, Brad A; Liu, Jiang; LoRusso, Patricia M; Oxnard, Geoffrey R

Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study

循环肿瘤DNA与组织和纵向循环肿瘤DNA基因分型相结合在晚期实体瘤中的益处:SCRUM-Japan MONSTAR-SCREEN-1研究

Takao Fujisawa,Yoshiaki Nakamura,Hideaki Bando,Chigusa Morizane,Masafumi Ikeda,Norio Nonomura,Nobuaki Matsubara,Hiroji Iwata,Yoichi Naito,Susumu Okano,Daisuke Aoki,Kenichi Harano,Naoya Yamazaki,Kenjiro Namikawa,Makoto Ueno,Shigenori Kadowaki,Eiji Oki,Ken Kato,Yoshito Komatsu,Taroh Satoh,Taito Esaki,Tadamichi Denda,Tetsuya Hamaguchi,Kentaro Yamazaki,Nobuhisa Matsuhashi,Hisateru Yasui,Hironaga Satake,Tomohiro Nishina,Naoki Takahashi,Masahiro Goto,Yu Sunakawa,Takeshi Kato,Tomoyuki Otsuka,Hikaru Abutani,Hanna Tukachinsky,Jessica K Lee,Geoffrey R Oxnard,Naomi Kuramoto,Satoshi Horasawa,Yasutoshi Sakamoto,Hiroya Taniguchi,Takayuki Yoshino

PL004. Reimagining Resilient Health Systems: Integrating Risk, Intelligence, and One Health for Safety: Moderators: Dimitrios Skempes (University of Thessaly), Ioanna Tsiligianni (University of Crete)

PL004. 重塑韧性卫生系统:整合风险、情报和一体化健康以保障安全:主持人:Dimitrios Skempes(塞萨利大学)、Ioanna Tsiligianni(克里特大学)

Schuman-Olivier, Zev; Fatkin, Thomas; Creedon, Timothy B; Samawi, Farah; Moore, Sarah K; Okst, Kayley; Fredericksen, Alaine Kiera; Oxnard, Alexandra Sasha; Roll, David; Smith, Lydia; Cook, Benjamin Lê; Weiss, Roger D; Mitchell, Rebecca; Petelos, Elena; Silva, Ivana; Dedes, Nikos; Chrysikou, Evangelia; Kehayia, Eva

Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types

循环肿瘤DNA能够灵敏地检测各种癌症类型中可靶向的基因融合和重排

Kasi, Pashtoon M; Lee, Jessica K; Pasquina, Lincoln W; Decker, Brennan; Vanden Borre, Pierre; Pavlick, Dean C; Allen, Justin M; Parachoniak, Christine; Quintanilha, Julia C F; Graf, Ryon P; Schrock, Alexa B; Oxnard, Geoffrey R; Lovly, Christine M; Tukachinsky, Hanna; Subbiah, Vivek

Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation

ctDNA肿瘤分数测定可识别有价值的阴性液体活检结果,并有助于评估组织确认的价值。

Rolfo, Christian D; Madison, Russell W; Pasquina, Lincoln W; Brown, Derek W; Huang, Yanmei; Hughes, Jason D; Graf, Ryon P; Oxnard, Geoffrey R; Husain, Hatim